Header cover image

Belgian Healthy high growth potential

Results

1

0 new

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1 companies

argenx

Market Cap: €42.4b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

ARGX

€682.00

7D

5.4%

1Y

33.6%